These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3133698)

  • 1. Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
    Ushijima I; Mizuki Y; Yamada M
    Psychopharmacology (Berl); 1988; 95(1):34-7. PubMed ID: 3133698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mode of action of bromocriptine following pretreatment with reserpine and alpha-methyl-p-tyrosine in rats.
    Ushijima I; Mizuki Y; Yamada M
    Psychopharmacology (Berl); 1988; 95(1):29-33. PubMed ID: 2898789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
    Ushijima I; Tsutsumi C; Hara T; Soeda K; Kishimoto O; Kaneyuki H; Mizuki Y; Yamada M
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):463-70. PubMed ID: 2907957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yawning induced by apomorphine, physostigmine or pilocarpine is potentiated by dihydropyridine calcium channel blockers.
    Bourson A; Moser PC
    Psychopharmacology (Berl); 1990; 100(2):168-72. PubMed ID: 1689500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Age-related modification of dopaminergic-cholinergic neuronal interaction in rats].
    Kishimoto O
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):443-51. PubMed ID: 3250156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.
    Ushijima I; Mizuki Y; Imaizumi J; Yamada M; Noda Y; Yamada K; Furukawa T
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):196-201. PubMed ID: 4004417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of dilazep on cholinergic, dopaminergic, and purinergic systems in the rat.
    Ushijima I; Mizuki Y; Ukita T; Kaneyuki H; Inano S; Yamada M
    Pharmacol Biochem Behav; 1992 Nov; 43(3):673-6. PubMed ID: 1360158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats.
    Longoni R; Spina L; Di Chiara G
    Life Sci; 1987 Nov; 41(18):2135-45. PubMed ID: 2959833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic and nicotinic effects on yawning and tongue protruding in the rat.
    Ushijima I; Yamada K; Inoue T; Tokunaga T; Furukawa T; Noda Y
    Pharmacol Biochem Behav; 1984 Aug; 21(2):297-300. PubMed ID: 6541344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine induces climbing behaviour: possible D-1 or D-2 dopamine receptor involvement.
    Zarrindast MR; Shahed-Dirin K
    Psychopharmacology (Berl); 1990; 100(2):275-80. PubMed ID: 2305016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yawning produced by dopamine agonists in rhesus monkeys.
    Code RA; Tang AH
    Eur J Pharmacol; 1991 Aug; 201(2-3):235-8. PubMed ID: 1686760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.
    Zarkovsky AM; Cereska KS
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):383-6. PubMed ID: 2567965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice.
    Jackson DM; Ross SB; Hashizume M
    Psychopharmacology (Berl); 1988; 94(3):321-7. PubMed ID: 2895938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of morphine on yawning induced by cholinoceptor and dopamine D2 receptor activation in rats.
    Zarrindast MR; Jamshidzadeh A
    Br J Pharmacol; 1992 Mar; 105(3):675-8. PubMed ID: 1385751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.
    Yamada K; Furukawa T
    Psychopharmacology (Berl); 1980 Jan; 67(1):39-43. PubMed ID: 6768077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine produced more yawning in Sprague-Dawley rats than in F344 rats: a pharmacological study.
    Tang AH; Himes CS
    Eur J Pharmacol; 1995 Sep; 284(1-2):13-8. PubMed ID: 8549616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two inbred rat sublines that differ in spontaneous yawning behavior also differ in their responses to cholinergic and dopaminergic drugs.
    Urbá-Holmgren R; Santos A; Holmgren B; Eguíbar JR
    Behav Brain Res; 1993 Sep; 56(2):155-9. PubMed ID: 7902098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of stress on drug-induced yawning: constant vs. intermittent stress.
    Tufik S; de Luca Nathan C; Neumann B; Hipólide DC; Lobo LL; de Medeiros R; Troncone LR; Braz S; Suchecki D
    Physiol Behav; 1995 Jul; 58(1):181-4. PubMed ID: 7667418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.